What were the key takeaways from Ingevity's earnings call?

What is the market's earnings forecast for Ingevity next quarter?

What is Ingevity's gross profit margin?

What does Ingevity do and what are its main business segments?

What is the revenue and EPS growth rate for Ingevity year over year?

Did Ingevity beat or miss consensus estimates last quarter?

What is Ingevity's latest dividend and current dividend yield?

What guidance did Ingevity's management provide for the next earnings period?

- **Portfolio Restructuring Success**: $274M free cash flow (5-year high), 2.6x leverage, $300M share buybacks through 2027. 
- **Segment Resilience**: Performance Materials 53.8% EBITDA margin, Performance Chemicals +$45M EBITDA, APT 20% margin despite market headwinds. 
- **2026 Growth Targets**: Adjusted EPS $4.08-$5.20, free cash flow $225M-$250M, filtration-driven PM expansion. 
- **Strategic Priorities**: Asset sales (APT, Road Markings), regulatory tailwinds (China 7), and ICE/hybrid vehicle recovery.

**【CEO Summary Section】**
- **Strategic Portfolio Review**: Announced plans to grow adjusted EPS by 10% and free cash flow per share by 5% through 2027, with sales processes initiated for Advanced Polymer Technologies (APT) and Road Markings. 
- **Portfolio Optimization**: Completed sale of North Charleston CTO refinery and Industrial Specialties, reducing volatility and enhancing cash flow. 
- **2025 Performance**: Achieved 10% growth in adjusted EBITDA to $398M, 30.8% margins, and $274M free cash flow (highest in 5 years). 
- **Segment Highlights**: 
  - *Performance Materials*: Flat sales ($607M) despite auto industry challenges, 53.8% EBITDA margin. 
  - *Performance Chemicals*: EBITDA up $45M, driven by repositioning actions. 
  - *APT*: 15% sales decline due to market weakness, but 20% EBITDA margin maintained. 
- **2026 Guidance**: 
  - Adjusted EPS: $4.08-$5.20 
  - Sales: $1.1B-$1.2B 
  - Free Cash Flow: $225M-$250M (excluding $95M litigation payment). 
  - Share Buybacks: $300M through 2027. 

**【CFO Financial Commentary】**
- **Full Year 2025 Results**: 
  - Total sales: $1.3B (-8% YoY) 
  - Adjusted EBITDA: $398M (+10%) 
  - Adjusted EPS: $4.55 (+30%) 
  - Free Cash Flow: $274M (vs. $54M in 2024). 
- **Segment Breakdown**: 
  - *Performance Materials*: Flat sales, 53.8% margin. 
  - *Performance Chemicals*: EBITDA +$45M, 13.5% margin. 
  - *APT*: EBITDA -18%, 20% margin. 
- **Leverage Reduction**: Net debt/EBITDA reduced to 2.6x (vs. 3.5x in 2025). 
- **2026 Outlook**: 
  - Free Cash Flow: $225M-$250M 
  - CapEx: $40M-$60M 
  - Share Repurchases: $300M (excluding asset sale proceeds). 

**【Q&A Highlights】**
- **Asset Sales Progress**: APT and Road Markings sales processes progressing with strong interest; potential announcements by end-2026. 
- **Stranded Costs**: $15M annualized savings expected by year-end, with back-end weighted cadence. 
- **Performance Materials**: 2026 sales growth low single-digits, supported by pricing in automotive and filtration expansion. 
- **Filtration Growth**: Focus on high-value applications (water, pharma, food/beverage) leveraging hardwood activated carbon technology. 
- **Regulatory Tailwinds**: China 7 emissions standards (Tier 3 equivalent) and India emission regulations could drive demand for ICE/hybrid vehicles. 
- **Pavement Technologies**: Seasonal EBITDA (90% in Q2/Q3), targeting 18%+ margins post-Road Markings sale. 
- **Acquisition Strategy**: No near-term M&A focus; prioritize cash return and balance sheet strength.

Ingevity Corporation(NGVT)-20260226-2025 Q4 Earnings call transcript

- **$110M Industrial Specialties Sale**: Proceeds to reduce debt, with 2026 close expected.
- **Q3 Resilience**: 33.5% EBITDA margin, $118M free cash flow, and 2.7x net leverage (vs. 2.8x target).
- **Segment Performance**: PM flat to down year-over-year, APT down mid-teens, Road Technologies record sales.
- **Strategic Moves**: New PM leader Ruth Castillo, $25M share buybacks, and December Investor Update on portfolio review.

**【Management Opening Remarks】**
- Announced the sale of Industrial Specialties business for $110 million, expected to close in early 2026, with proceeds to be used for debt reduction.
- Highlighted strong Q3 execution across segments: Performance Materials and Road Technologies delivered record sales, while APT faced challenges from weak end-market demand and competitive dynamics.
- Appointed Ruth Castillo as leader of Performance Materials, emphasizing strategic growth and operational improvements.
- Provided full-year guidance, including free cash flow and net leverage targets, with plans to accelerate debt reduction.

**【CEO Commentary】**
- Q3 results demonstrated resilience across businesses, with Performance Materials and Road Technologies outperforming despite global auto production challenges.
- Emphasized the company's strategic focus on profitable growth, disciplined capital allocation, and operational efficiency.
- Highlighted the importance of the automotive industry's shift to hybrids and fuel-efficient ICE platforms for future demand in Performance Materials.
- Announced an Investor Update on December 8 to discuss strategic portfolio review and future business direction.

**【CFO Financial Commentary】**
- Total company sales of $362 million for Q3, down 4% year-over-year, driven by lower Industrial Specialties sales and APT challenges.
- Adjusted EBITDA margin improved to 33.5%, reflecting cost control and lower raw material costs.
- Free cash flow of $118 million enabled $25 million in share repurchases and net leverage reduction to 2.7x, ahead of target.
- Full-year guidance updated to reflect ongoing challenges in APT and stable Performance Materials outlook.

**【Q&A Highlights】**
- Performance Materials segment resilience despite supply chain disruptions (aluminum plant fires, chip shortages) and tariffs, with Q3 results demonstrating operational strength.
- APT segment faced weak demand in footwear/apparel and competitive pressures in China, but maintained 26% EBITDA margin through cost management.
- Divestiture of Industrial Specialties expected to contribute $40 million annual free cash flow and reduce stranded costs by $15 million by 2026.
- Management reaffirmed commitment to disciplined capital allocation and debt reduction, with plans to use sale proceeds for further deleveraging.

Ingevity Corporation (NGVT) Q3 2025 Earnings Call Transcript

- **Strategic Progress**: Advanced sale process for Industrial Specialties and CTO refinery; EBITDA guidance raised to $390-415M.
- **Financial Strength**: 30.1% adjusted EBITDA margin, free cash flow guidance increased to $230-260M, net leverage target of <2.8x.
- **Segment Performance**: Performance Materials EBITDA >50%, Performance Chemicals margin approaching 20%, APT facing mid-single-digit revenue decline.
- **CTO Cost Efficiency**: Current purchases at $550-600/ton, eliminating high-cost inventory drag.
- **Future Focus**: Investor update on portfolio review and long-term strategy expected late 2025/early 2026.

**【Management Opening Remarks】**
- John Nypaver introduced the call, outlining the agenda and cautioning about forward-looking statements. He highlighted the company's focus on execution excellence and strategic portfolio assessment.

**【CEO Summary Section】**
- CEO David Li emphasized the company's strong execution, profitability, and free cash flow, noting a 3x net leverage improvement in less than a year. He highlighted the sale process for Industrial Specialties and CTO refinery, which is in an advanced stage.
- Li shared updates on the strategic portfolio review, including plans for an investor update later in the year to discuss long-term growth strategy and vision.
- The company raised full year EBITDA guidance to $390 million to $415 million and free cash flow guidance to $230 million to $260 million, reflecting confidence in achieving a net leverage target of below 2.8x by year-end.

**【CFO Financial Commentary】**
- CFO Mary Dean Hall reported Q2 sales of $365 million, down 7% YoY due to repositioning actions and external factors. Adjusted gross margin improved by 600 basis points, driving a 9% increase in adjusted gross profit.
- Adjusted EBITDA margin rose to 30.1%, with significant contributions from Performance Materials (EBITDA margin >50%) and Performance Chemicals (EBITDA margin approaching 20%).
- A noncash goodwill impairment charge of $184 million was recorded for the APT segment due to tariff-related demand weakness. Full year APT revenue is expected to decline mid- to high single digits, with EBITDA margin between 15% and 20%.
- Free cash flow guidance was raised, reflecting disciplined working capital management and lower CapEx.

**【Q&A Key Highlights】**
- **Performance Chemicals Margins**: Second half margins expected to match first half, with benefits from lower CTO costs and repositioning efforts.
- **Free Cash Flow Drivers**: Improved earnings, inventory management, and predictable cash flows from core businesses.
- **Strategic Portfolio Review**: Ongoing assessment of entire portfolio, with a focus on core competencies and value creation. Investor update expected late 2025 or early 2026.
- **CTO Pricing**: Current purchases at $550-$600/ton, down from prior high-cost inventory, reducing market dependency.
- **Capital Allocation**: Priorities include debt reduction, organic growth investments, and potential share repurchases post-leverage target achievement.


Ingevity Corporation (NGVT) Q2 2025 Earnings Call Transcript

- **Record Profitability**: 400bps gross margin expansion to 45.4%, EBITDA margin 32.1% vs. 21.9% last year.\n- **Tariff Resilience**: Minimal direct impact; 90%+ production local for local markets.\n- **Auto Risk Mitigation**: $15-20M EBITDA downside hedge via filtration market pivot (50% lower margin).\n- **Debt Reduction**: Leverage down to 3.3x from 4.3x Q1 2024, targeting <2.8x by year-end.\n- **Strategic Shifts**: Exits low-margin businesses, exploring Industrial Specialties sale, and investing in EV filtration tech.

**【CEO Opening Remarks】**
- Q1 2025 revenue of $284M reflects 4th consecutive quarter of margin expansion, driven by repositioning actions in Performance Chemicals and cost savings.\n- Gross margin improved 1,000bps to 45.4%, with EBITDA margin rising to 32.1% vs. 21.9% last year.\n- Tariff impact on business is minimal; mitigation plans include localization, pricing adjustments, and inventory management.\n- Auto industry forecast for 10% Y/Y decline in North American production has widened guidance range, with potential $15-20M EBITDA impact.\n- Focus on disciplined execution, reducing leverage to <2.8x by year-end, and exploring strategic options for Industrial Specialties.\n\n**【CFO Financial Breakdown】**\n- **Performance Materials**:\n  - Sales $108M (+10% vs. Q1 2024) due to price increases, China gov't incentives, and U.S. volume growth in hybrids.\n  - EBITDA margin 54%, with sensitivity to auto production decline.\n  - Tariff mitigation via in-country inventory and price adjustments.\n- **Advanced Polymer Tech**:\n  - Sales $60M (-11%) due to Asia inventory drawdown, but EBITDA up $3M to 29.6% margin.\n  - New President Michael Shukov driving operational excellence.\n- **Performance Chemicals**:\n  - Sales $116M (-35%) as lower-margin businesses exit.\n  - EBITDA +$10M YoY from cost savings and lower CTO costs.\n  - Strategic review of Industrial Specialties progressing.\n\n**【Q&A Highlights】**\n- **Tariff Strategy**:\n  - Local production for local markets minimizes impact.\n  - Pricing surcharges and inventory management used as levers.\n- **Filtration Market**:\n  - Can absorb excess capacity but at lower margins (~50% of auto margins).\n- **EV Impact**:\n  - Nexeon battery tech R&D continues despite EV slowdown.\n  - Hybrids (stop-start, turbo) remain key growth driver.\n- **Leverage Target**:\n  - Long-term goal of 2.0-2.5x; current 3.3x vs. Q1 2024's 4.3x.\n  - Free cash flow expected to accelerate in H2.

Ingevity (NGVT)-6 May 25-2025 Q1 Earnings call transcript

- **PM Dominance**: 2024 EBITDA margins hit 52.3%, driven by auto industry shift to hybrids and ICE vehicles.
- **Debt Reduction**: Free cash flow of $51M reduced net leverage to 3.5x, targeting 2.8x by 2025.
- **CTO Transition**: High-cost inventory to be exhausted by Q2 2025, with pricing already competitive.
- **Strategic Flexibility**: Exploring alternatives for Industrial Specialties, with external interest in assets.
- **Tariff Watch**: No immediate impact, but monitoring for potential demand shifts.


**【CEO Opening Remarks】**
- **Strategic Repositioning Success**: 2024 saw a shift to higher-margin markets, with Performance Materials (PM) sales up 4% vs. global auto production growth of 2%, and EBITDA margins hitting 52.3%.
- **Free Cash Flow Achievement**: Generated $51M in free cash flow despite $200M in repositioning costs, reducing net leverage to 3.5x.
- **2025 Outlook**: Guiding for $1.3B-$1.4B in sales and $400M-$415M in EBITDA, targeting net leverage below 2.8x by year-end.

**【CFO Financial Review】**
- **Topline Performance**: Full-year sales $1.4B (-17% YoY), driven by PM's record $665M (+4%) offset by $300M drop in Performance Chemicals (PC) due to market exits.
- **Profitability Improvements**: Adjusted EBITDA margin rose 350bps to 25.8%, with PM margins at 52.3% and PC EBITDA of $14.7M vs. breakeven guidance.
- **Cash Flow Discipline**: Working capital management delivered $50M benefit, with 2025 free cash flow guidance of $220M-$260M.

**【Q&A Highlights】**
- **CTO Inventory Impact**: High-cost CTO inventory to be fully consumed by Q2 2025, with pricing already aligned to current market levels.
- **Auto Market Trends**: Hybrids and ICE vehicles dominate PM content, aligning with S&P Global forecasts of stable EV demand.
- **Strategic Alternatives**: Exploring options for Industrial Specialties and North Charleston refinery, with interest from external parties.
- **Tariff Uncertainty**: No immediate impact on orders, but monitoring potential demand shifts.
- **R&D Investment**: Focused on battery applications (e.g., Nexeon silicon anodes), with R&D spend offsetting PM margin expansion.


Actual											1.12	0.63	1.79	1.33	1.27	1.55	1.62	0.78	1.62	1.73	2.09	0.57	1.09	1.41	1.21	0.21	0.52	1.01	1.1	0.95	0.99	1.39	1.52	0.63
Forecast											0.8045	0.6033	1.0146	0.7757	1.03	1.3188	1.54	0.775	1.0365	1.6229	1.6931	0.8657	1.1314	1.3729	1.2142	-0.0953	0.338	1.054	0.882	0.3086	0.7377	1.1625	1.3675	0.665
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+39.22%	+4.43%	+76.42%	+71.46%	+23.30%	+17.53%	+5.19%	+0.65%	+56.30%	+6.60%	+23.44%	-34.16%	-3.66%	+2.70%	-0.35%	+320.36%	+53.85%	-4.17%	+24.72%	+207.84%	+34.20%	+19.57%	+11.15%	-5.26%

NGVT

NGVT fundamentals

NGVT Q4 2025 Earnings

Earnings Call

You can ask Aime

NGVT

NGVT fundamentals

NGVT Q4 2025 Earnings

Earnings Call

NGVT Earnings Call Summary for Q4/202510:00 AM on Feb 26, 2026

NGVT Earnings Call Summary for Q3/202510:00 AM on Nov 6, 2025

NGVT Earnings Call Summary for Q2/202510:00 AM on Aug 5, 2025

NGVT Earnings Call Summary for Q1/20259:00 AM on May 6, 2025

NGVT Earnings Call Summary for Q4/202410:00 AM on Feb 19, 2025

You can ask Aime